Home › Jubilant Biosys Announces Successful Filing Of Investigational New Drug With US-Based Endo Pharmaceuticals
 

Keywords :   


Jubilant Biosys Announces Successful Filing Of Investigational New Drug With US-Based Endo Pharmaceuticals

2013-09-04 06:25:07| drugdiscoveryonline News Articles

Jubilant Biosys Ltd., a Bengaluru-based subsidiary of Jubilant Life Sciences Ltd., announced recently the US FDA acceptance of the IND filing for a novel molecule targeting prostate cancer with Endo Pharmaceuticals of the US

Tags: successful drug filing announces

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
08.11Nissan to lay off thousands of workers as sales drop
08.11Hurricane Rafael Graphics
08.11Hurricane Rafael Wind Speed Probabilities Number 18
08.11Hurricane Rafael Forecast Discussion Number 18
08.11Hurricane Rafael Forecast Advisory Number 18
08.11Hurricane Rafael Public Advisory Number 18
08.11Summary for Hurricane Rafael (AT3/AL182024)
08.11Up close with the 300 tonne driverless trucks
More »